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Role of the ioop segment in the urinary concentrating defect of
hypercalcemia
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Role of the loop segment in the urinary concentrating defect of
hypercalcemia. Hypercalcemia is associated with impaired urinary
concentrating ability. To explore the mechanism(s) by which
hypercalcemia impairs chloride transport in the ioop of Henle, we
carried out in vivo microperfusion of the loop segment in Sprague—Daw-
Icy rats rendered acutely hypercalcemic (12.1 0.1 mgldliter) by
calcium gluconate infusion. Control rats were infused with sodium
gluconate and had normal plasma calcium (8.0 0.2 mgldliter).
Compared to control, fractional chloride reabsorption was decreased
(61 4 to 50 3%;P < 0.05) and early distal chloride increased 74
6 to 98 3 mEq/liter (P < 0.001) in hypercalcemia. During
hypercalcemia, infusion of verapamil failed to increase fractional chlo-
ride reabsorption (49 4%; P < 0.05) or decrease early distal chloride
(95 2; P < 0.05) toward control values. Similarly, indomethacin did
not improve fractional chloride reabsorption (48 4%; P < 0.05) or
distal chloride concentration (93 7; P < 0.05). In control rats infused
with Ringers HCO3, the addition of calcium 8.0 mEq/liter to the
perfusate increased early distal calcium (0.22 to 3.11 mEq/liter) but was
associated with no change in fractional chloride reabsorption (—6
6%) and a slight decrease in early distal chloride (—9 3 mEq/liter; P
<0.05). These data are consistent with the hypothesis that an elevated
plasma, not luminal calcium, concentration impairs chloride reabsorp-
tion in the loop segment, primarily the ADH—stimulated component.
This may have an important role in the urinary concentrating defect of
hypercalcemia.
Hypercalcemia is associated with impaired renal concentrat-
ing ability in humans and experimental animals due to several
proposed mechanisms [1, 21. In the rat, Manitius et al produced
hypercalcemia by excess vitamin D administration, and showed
decreased papillary sodium and urea content [3]. This decrease
in medullary hypertonicity in hypercalcemia has been attributed
to a number of functional derangements. First, impaired trans-
port in Henle's loop has been suggested by the observations of
reduced free water reabsorption in dogs and rabbits after acute
infusions of calcium salts [4—7]. Second, reduction in GFR has
been shown in several of these models [3, 4, 8] and has
suggested that a decrease in solute delivery to Henle's loop may
be an important mechanism. Finally, Brunette et a! showed
enhanced medullary blood flow which, they suggested, may
promote a reduction in papillary solute content [6].
To determine whether and by what mechanism decreased net
chloride uptake within the ioop of Henle occurs during
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hypercalcemia, chloride transport in the loop segment (LS) of
superficial nephrons was studied by microperfusion techniques
in normocalcemic and hypercalcemic rats. The responses to
verapamil or indomethacin infusion and the effect of increased
luminal calcium concentration without a change in plasma
calcium concentration were studied.
Methods
All studies were carried out in male Sprague—Dawley rats
which weighed between 220 and 390 g and were maintained on
regular rat chow (Wayne Lab Blox, Chicago, Illinois, USA) and
tap water until the day of experiment. Rats were anesthetized
with mactin (BYK Gulden Konstanz, FRG) 100 mg/kg body wt
(BW) i.p. and placed on a servo-controlled heated table. Rectal
temperature was monitored by a telethermometer (Yellow
Springs Inst. Corp., Yellow Springs, Ohio, USA) and main-
tained at 37°C throughout the experiment. A tracheostomy was
performed and PE-50 catheters were placed in the jugular vein
for the infusion of solutions, in the right femoral artery for the
continuous monitoring of blood pressure and intermittent blood
sampling, and in the bladder for timed urine collections. Arte-
rial pressure was determined with a model P231D transducer
(Gould—Statham Inst., Inc., Hato Rey, Puerto Rico) and re-
corded on a model 7D polygraph (Grass Inst. Co., Quincy,
Massachusetts, USA). The left kidney was exposed through a
flank incision and the perirenal fat was removed. The kidney
was placed in a Lucite cup and warmed agar was placed around
the kidney to form a well on the surface. Polyfructosan 2%
(mutest, Laevosan Gesellschaft, Linz, Austria) was added to all
infusion solutions in sufficient amounts to sustain a plasma
concentration of about 1 mg/dliter. The kidney was bathed
continually with the infusate without mutest. After 60 mm of
equilibration, two 60 mm clearance periods were carried out
during which microperfusion was performed. Blood was sam-
pled periodically for determination of inulin and chloride con-
centrations and timed urine collected for determination of
volume and inulin concentrations. The experiment was termi-
nated by aortic puncture and plasma concentrations of chloride
and calcium were determined.
The degree of hypercalcemia that would produce a defect in
concentrating ability was confirmed in a group of rats (HICA- 1)
which were rendered hypercalcemic by daily subcutaneous
injections of calciferol, 175,000 units (Taylor Pharmacal Co.,
Decatur, Illinois, USA) in oil for three days. Control rats
(CON-I) were given sesame oil injections, Animals were al-
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lowed free access to food and tap water. Drink was removed in
the afternoon of the fourth day and urine was collected until
0700 of the fifth day, and again until 1500 for determination of
osmolality. The animals were then sacrificed and plasma cal-
cium concentration was determined on aortic blood.
Microperfusion of the LS was performed as previously de-
scribed [9]; a brief summary follows. The LS includes a short
terminal section of the proximal convoluted tubule (PCT), the
proximal straight tubule (PST), the thin descending limb (tDL)
ofHenle's loop, the medullary and cortical thick ascending limb
(TALH) and a short initial segment of the distal convoluted
tubule (DCT). A pipet filled with FD and C Green—tinted
non-radioactive perfusate was inserted into a proximal tubule at
random and a small bolus injected to identify both latest surface
proximal and earliest surface distal sites. A perfusion pipet was
inserted into the latest accessible surface proximal tubule and
the perfusion begun at 22 nliter/min with a precalibrated
microperfusion pump (World Precision Instruments, New Ha-
ven, Connecticut, USA). The perfusate consisted of (in mM):
KCI, 5; MgSO4, 1; NaHCO3, 10; NaH2PO4, 1; CaC12, 1; urea,
4.2; and NaCI, 130. Sufficient methoxy-3H inulin was added to
yield 100 to 150 cpm/nliter. A pipet was inserted proximal to the
perfusion pipet to inject a small cast of bone wax. The segment
proximal to this block was then vented. After I to 2 mm of
perfusion to insure satisfactory flow, a collection pipet was
inserted into the distal tubule site. An oil block was inserted and
a complete timed collection obtained. Two to six tubules were
perfused in each animal.
Acute hypercalcemia was produced by the infusion of
Ringers—bicarbonate and calcium gluconate, 62 mEq/liter at a
rate of 3 mliter/100 g BW/hr for 1 hr, and thereafter at 3
mliter/hr. Group HICA-2 (N = II) received this infusate only.
To determine whether antagonism of calcium entry blockade
altered the responses to hypercalcemia, verapamil (Searle Phar-
maceuticals Inc, Chicago, Illinois, USA) 0.02 mg/kg/hr was
added to the infusate in group HICA-3 (N = 8) [10]. To
determine the role of prostaglandins on the observed defect in
chloride transport. indomethacin (Sigma Co., St. Louis, Mis-
souri, USA) 5 mg/kg was infused as a bolus followed by a
sustaining dose of 6 mg/kg/hr in group HICA-4 (N = 9) [11].
'l'he control group (CON-2; N = 9) was infused with
Ringers—bicarbonate consisting of: Na, 140; Cl, 100; K, 4.0;
HCO3, 25; acetate, 20; Mg, 1.2; Ca, 1.2; phosphate, 1.2;
dextrose, 5.3; and sodium gluconate 62 mEq/liter at 3 muter/tOO
g BW/hr for I hr and thereafter at 3 muter/hr.
The effects of elevated luminal calcium concentration were
determined in separate groups of rats (group CON-3; N = 7)
which were infused with Ringers-bicarbonate at 1.2 mliter/lOO g
BW/hr. Separate tubules in each animal were perftised with
artificial tubule fluid containing calcium at a concentration of
either 0.5 or 8.0 mEq/liter and 45Ca * 2 tg/mliter.
Analytical techniques
Methods for determination of volume, chloride, and inulin
were as described previously [91. Plasma calcium concentration
was determined by a modified method of Kessler and Wolfman
[12]. 45Ca + activity was determined by liquid scintillation
counting (Packard Tn Carb, Model 3255, Packard instrument
Co., Downers Grove, Illinois, USA). Appropriate corrections
for crossover counts and background activity were made and
quench corrections were determined by an internal standard. In
each experiment perfusate and collectate 45Ca + activity were
determined by the same techniques.
Calculations
Clearance and excretion rates were calculated by standard
expressions [9]. In vivo perfusion rate (PR) was calculated by
the expression:
PR = CR x 3H2/3H1 (nliter/min)
in which CR = distal collection rates, 3H1 3H inulin
counts/min/nliter in the perfusate, and 3H2 in collectate. Only
perfusions with a calculated rate of >15 and <25 nliter/min
were accepted. Fractional chloride reabsorption (FR Cl) was
calculated as:
FR Cl [(Cl1 x PR) — (Cl2 x CR)j/(Cl1 x PR)
in which Cl1 and Cl2 are the chloride concentrations in the
perfusate and the collectate respectively.
The concentration of calcium in the early distal tubule
(EDca + +) was estimated by the expression:
EDa [(45Ca1 x PR) — (45Ca2 x CR)/(45Ca1 x PR)]
X PFça X 3H1/3H2
in which 45Ca + and 45Ca 2 are the perfusate and collectate
45Ca + + counts/min/nliter and PFa + + is the perfusate calcium
concentration.
Values are given as mean SEM. For microperfusion data a
single mean value is calculated for each variable in each animal
and used to calculate the mean value for each group. Statistical
significance was determined by an unpaired Student's 1-test
between groups and a paired t test within groups. Significance
was set at the 5% level.
Results
In the vitamin D-treated rats (HICA-1), urine osmolality was
2025 124 on day four and 2367 83 on day five compared
with 2752 67 and 3290 134 (P < 0.02 and 0.005, respec-
tively) in controls (CON-i). Plasma calcium concentrations on
day four were 11.4 0.6 (HICA-l) and 9.8 0.3 mEq/liter
(CON-I) (P < 0.05).
Body wt, blood pressure, and plasma chloride concentrations
did not differ among the groups studied by microperfusion
(Table I). Plasma calcium concentrations in all HICA groups
were higher than that in group CON-2 and were in the range
shown to produce a decrease in urine osmolality after water
deprivation. Inulin clearance in group CON-2 was lower than
those in groups HICA-2 and HICA-3; inulin clearances in these
latter groups did not differ from that in group CON-3. Tubule
perfusion rates did not differ (Table 2).
Compared to group CON-2, hypercalcemia (group HICA-2)
was associated with a decrease in fractional chloride reabsorp-
tion in the LS (50 3 vs. 61 4%) and an increase in early
distal tubule fluid chloride concentration (98 3 vs. 74 6
mEq/liter); the decrease in absolute chloride reabsorption (1422
81 vs. 1686 94 pEq/min) was not significant (P < 0.07 >
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Table 1. Systemic variables for microperfusion studies.
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Mean Final Final
arterial plasma plasma Inulin
Body wt pressure calcium chloride clearance
Group g mm Hg mg/dliter mEqiliter piiter/min
CON-2 288 14 116 3 8.0 0.2 99 2 962 82
HICA-2 264 II 118 6 12.1 0.5a 102 2 1483 l91
HICA-3 255 14 108 2 11.5 0.6a 103 1 1273 176
HICA-4 251 9 118 4 11.2 0.2a 104 1 826 108
CON-3 270 11 115 2 — 103 2 1276 179
a P < 0.05 compared to CON-2.
Group
Perfusion
rate
nliter/min
Fluid
reabsorption
%
CON-2 21.2 0.5 34 2
HICA-2 21.2 0.5 33 4
P valuea NS NS
HICA-3 20.1 0.6 29 5
P valuea NS NS
HICA-4 20.6 0.8 22 3
P valuea NS <0.01
a Compared to group CON-2.
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0.05) (Figs. 1—3). In hypercalcemic rats infused with the calcium
entry blocker, verapamil (group HICA-3), absolute chloride
reabsorption (1292 102 pEq/min), early distal tubule fluid
0Tfl
Control HICA HICA HICA
+ +
Verapamil Indomethacin
Fig. 2. Comparison of the early distal tubule fluid chloride concentra-
tions among the hypercalcemic groups in which the ioop segment was
perfused. *D < 0.05 compared to control.
chloride concentration (95 2 mEq/liter) and fractional chlo-
ride reabsorption (49 4%) failed to improve (Figs. 1—3).
Similarly, indomethacin infusion (group HICA-4) failed to cor-
rect absolute (1314 124 pEq/min) or fractional (48 4%)
chloride reabsorption or early distal chloride concentration (93
7 mEq/liter) (Figs. 1—3). Fractional fluid reabsorption was
lower in group HICA-4 (Table 2).
High perfusate calcium concentrations (8 mEq/liter) in-
creased estimated early distal tubule fluid calcium concentra-
tion (Table 3). Nevertheless, absolute and fractional chloride
reabsorptions did not differ from control perfusates with 0.5
mEq/liter calcium. Early distal tubule fluid chloride concentra-
tion was lower with the 8 mEq/liter perfusate.
Discussion
Our data show that, in the rat, moderate acute hypercalcemia
is associated with an almost 20% reduction in fractional chlo-
ride reabsorption in the LS and a 25% increase in early distal
tubule fluid chloride concentration. A decrease in renal concen-
Table 2. Microperfusion data for hypercalcemic groups. 110
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Fig. 1. Comparison of fractional chloride reabsorption in the perfused
loop segment among the hypercalcemia groups. *p < 0.05 compared to
control.
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HICA HICA
+ +
Verapamil Indomethacin
Fig. 3. Comparison of absolute chloride reabsorption in the perfused
loop segment among the hypercakemic groups. *O < 0,05 compared to
control.
trating ability was confirmed for a similar degree of
hypercalcemia lasting 72 hr in unanesthetized rats. The approx-
imately 50% increase in plasma calcium concentration in our
study is similar to that in other studies in which the acute
infusion of calcium salts has been used to induce and investigate
the urinary concentrating defect [4, 5, 7]. During acute
hypercalcemia, the defect in chloride uptake was not corrected
either by calcium entry blockade with verapamil or
prostaglandin inhibition with indomethacin.
Although the LS comprises several nephron segments, we
interpret our data to relate most directly to active NaC1 trans-
port in the 'l'ALH for the following reasons: since TALH is
virtually impermeant to water, any alteration in net fluid trans-
port in the LS would occur mainly in either the PST or the tDL.
If the principal effect of hypercalcemia were in the PST or the
tDL, a decrease in fluid reabsorption should accompany the
observed decreases in chloride uptake. More severe
hypercalcemia than that produced in our study can decrease
fluid reabsorption in the PCT [13, 14]; a similar effect could
occur in the PST. Medullary washout could also have reduced
fluid reabsorption in the tDL which might then induce flow—re-
lated changes in chloride uptake in the TALH. Because net LS
fluid reabsorption, in fact, did not change in hypercalcemia
alone (group HICA-2), it is most likely that Cl uptake was
altered by an effect of hypercalcemia in the TALH.
In the isolated perfused rabbit cortical TALH, Shareghi and
Agus noted a decrease in transepithelial potential difference
(PD) when either the luminal or bath calcium concentration was
doubled [15]. However, because they did not directly examine
fluid or NaCI transport and we did not determine PD, compar-
ison between these studies is inferential. Quamme [14] perfused
the LS of thyroparathyroidectomized Wistar rats in vivo at 25
nliter/min and showed decreased sodium and chloride reabsorp-
tion when plasma calcium concentration was increased from 2.2
to 4.2 mM/liter by CaCl2 infusion. Thus, our data are not only in
concert with these observations despite the differences between
the protocols but also show an effect at a more moderate degree
of hypercalcemia which is more often observed clinically.
In contrast, Bank and Aynedjian found no differences in the
tubule fluid to plasma osmolality ratios all along the surface
DCT between normocalcemic and hypercalcemic rats during
mannitol—saline diuresis at an unspecified infusion rate [8].
They inferred that no defect in sodium and, presumably,
chloride transport was present in the nephron to the DCT.
Differences between our protocol and theirs—especially the
effects of an osmotic diuresis—and the marked decrease in GFR
in their study may explain, in part, the opposing conclusions.
Hebert and Andreoli [16] have proposed a model of NaCl
reabsorption in the TALH in which prostaglandins (PG) mod-
ulate ADH-stimulated NaCI co-transport. In support of that
model, Andreoli and coworkers [16, 17] showed in the murine
medullary TALH that PGE2 did not alter the transepithelial PD
or chloride reabsorption in the absence of ADH and that cAMP
could stimulate transepithelial PD and chloride uptake in the
presence of ADH. In addition, 'l'orikai and Kurokawa [181 have
shown that ADH-stimulated cAMP formation is inhibited by
PGE2 in both the cortical and medullary segments of the
isolated TALH of the rat. In the LS of the rat in vivo,
Higashihara et al [11] have shown by free—flow micropuncture
that indomethacin increases chloride reabsorption, and we have
shown that indomethacin enhances primarily the ADH-stimula-
ted component of chloride reabsorption [191. in our microperfu-
sion study, fractional chloride reabsorption increased and distal
chloride concentration decreased (P < 0.05) after indomethacin
in Sprague—Dawley rats and in Brattleboro rats given ADH but
not in Brattleboro rats without ADH replacement, data which
further support the model proposed by Hebert and Andreoli.
Hypercalcemia increases urinary PGE2 excretion and, by
inference, renal PGE2 synthesis, but the extent to which
calcium and prostaglandins interact to influence the action of
ADH is controversial [20, 21]. In the present study, indometh-
acm was infused in sufficient doses to inhibit PGE2 synthesis by
95% [11] but failed to correct the defective LS chloride trans-
port induced by hypercalcemia. Fluid reabsorption also was
decreased in the LS in this group (about 2.5 nliter/min) unlike
that in group HICA-2 or any of the indomethacin—treated rats
previously mentioned [19]. However, PG are not known to
influence transport in the proximal tubule [22] and, based on
estimates of cortical thickness and rates of Iluid reabsorption in
the mammalian PST [23], only about 0.75 nliter/min of fluid
would be reabsorbed in the PST. Thus, even if transport in the
PST were completely inhibited, this segment would not account
for the observed small decrease in fluid reabsorption, On the
other hand, passive fluid uptake in the tDL is influenced by
medullary blood flow which conceivably could have been
altered by an interaction between hypercalcemia and PG inhi-
bition in a manner to decrease fluid uptake at this site. How-
ever, in this instance, only fluid and not chloride delivery to the
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Table 3. Effect of perfusate calcium concentration on ioop segment function
Perfus
0.5 mEq/liter
ate Ca
8.0 mEq/Iiter
Difference
N=8 P valuea
Collectate Ca" mEq/liter
Perfusion rate nI/mm
Fluid reabsorption %
Cl reabsorption pEq/min
0/0
Collectate Cl mEqiliter
0.22 0.06
19.5 1.0
42 4
1558 145
62 4
81 3
3.11 0.43
19.6 0.9
26 7
1412 244
55 6
72 4
+2.44
+0.l0
— 16
—147
—6
—9
0.48
1.27
8
236
6
3
<0.001
NS
NS
NS
NS
<0.05
0 Paired Student's i-test.
TALH would be increased. Increased delivery (load) should
result in increased absolute chloride reabsorption, decreased
fractional chloride reabsorption, and increased distal chloride
concentration [24—261. Since no differences in the indices of Cl
uptake were observed in group HICA-4 compared to group
HICA-2, there were no additional effects of this small increase
in fluid delivery. Thus, PG inhibition did not detectably alter Cl
uptake in the LS during hypercalcemia. These data suggest that
hypercalcemia has already suppressed that component of chlo-
ride reabsorption in the LS modulated by PG, that is, the
ADH-stimulated component. This interpretation is congruent
with the conclusion of Beck et a! [271 that the urinary concen-
trating defect in hypercalcemic rats is due in part to a direct
inhibitory effect of calcium on the ADH-responsive cyclic AMP
system.
Cytosolic calcium has been shown to modulate sodium trans-
port in several epithelia including toad and turtle bladders, frog
skin, and rabbit proximal and collecting tubules [281. For
example, the calcium ionophore, A-23 187, inhibits sodium
transport in the toad bladder, the magnitude of which is
dependent upon extracellular calcium concentration; this inhi-
bition is reversed by ADH [281. In water—diuresing
thyroparathyroidectomized rats, Humes, Simmons, and Bren-
ner [101 showed that verapamil prevented an increase in urinary
osmolality that had occurred in response to parathyroid hor-
mone (PTH) infusion. Although it is not known if cytosolic
calcium is increased by hypercalcemia [29], they suggested that
verapamil had a direct antagonistic effect on a PTH-stimulated
event, perhaps an increase in intracellular calcium. While the
site of action of the observed effects in their study is also
unknown, PTH-responsive adenylate cyclase abounds in the
cortical TALH of the rat [30]. Similarly, verapamil did not
correct the chloride transport defect in the LS induced by
hypercalcemia in the present study. This may indicate that the
TALH epithelium does not possess calcium channels that can
be blocked by verapamil or that the drug does not alter the
defect in chloride uptake. Clearly, further investigation of these
interactions is necessary to elucidate their mechanism. In
agreement with our observation, Takaichi, Uchida, and
Kurokawa [31] recently reported that extracellular calcium per
se suppressed ADH-dependent adenylate cyclase in the medul-
lary TALH but not in collecting tubule, and that this effect was
not reversed by either verapamil or diltiazem.
In contrast with calcium infusion, no defect in chloride
uptake in the LS was observed when the increase in calcium
concentration was limited to the tubule lumen (group CON-3).
Although fractional fluid reabsorption in the LS of these nor-
mocalcemic rats was unchanged as shown by statistical analy-
sis, the decrease appears large. Even if the decrease in fluid
reabsorption were significant, none of the expected flow—re-
lated changes occurred [24—26]; collectate chloride concentra-
tion actually decreased. Conceivably, the high perfusate cal-
cium concentration decreased chloride transport in the PST but
increased it in the TALH. Such a possibility would be consist-
ent with our data, but clearly it cannot explain the observed
defect in net chloride uptake produced by infused calcium.
We did not examine either impaired collecting duct responses
to antidiuretic hormone (ADH) [321 or increased medullary
blood flow [6, 33]. Increased blood flow would decrease med-
ullary interstitial hyperosmolality which, in turn, would de-
crease the transepithelial chloride gradient in the TALH and
thus, cannot, per Se, explain our findings of impaired chloride
reabsorption. However, either of these defects may contribute
to the concentrating defect via effects in other nephron seg-
ments.
Based on our observations, we conclude that acute
hypercalcemia per se and not the consequent increase in
luminal calcium concentration inhibits chloride transport in the
LS of the rat independently of fluid or chloride load to that
segment. This defect may be mediated by an effect of extracel-
lular calcium on ADH-stimulated chloride reabsorption in the
TALH. In a recent review of the role of calcium in the action of
ADH including a consideration of hypercalcemia, Levine and
Schlondorff [30] raised the possibility that calcium inhibits both
urinary concentration and sodium (chloride) reabsorption by
inhibition of adenylate cyclase in the TALH. Subsequently,
Berl et a! [34] reported marked inhibition of cAMP accumula-
tion after ADH in TALH but not in medullary collecting ducts
from hypercalcemic rats. They concluded that this may impor-
tantly contribute to the concentration defect; our data further
support this conclusion.
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